Delivery Order SPE2DB24D2205-SPE2DB24FDVVH

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,709.21 with a completion date of February 21, 2025. The contract is for the supply of ANNOVERA vaginal rings and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,215.35 firm fixed-price delivery order covers the supply of ANNOVERA vaginal rings, with a period of performance through January 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of ANNOVERA vaginal rings to the Defense Logistics Agency (DLA), a defense agency. The $15,617.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,106.66 Firm Fixed Price Delivery Order is for the supply of ANNOVERA vaginal rings, with a performance period ending on May 9, 2024. Amerisourcebergen, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,506.26, is for the delivery of ANNOVERA vaginal rings. It is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $2,348.82 firm-fixed-price delivery order is for the supply of ANNOVERA vaginal rings, with an ultimate completion date of April 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,117.03, is for the delivery of ANNOVERA vaginal rings. It is a Firm Fixed Price Delivery Order contract with a period of performance through February 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of ANNOVERA vaginal rings. The $2,992.98 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,983.30 firm fixed-price delivery order contract is for the supply of ANNOVERA vaginal rings, with a period of performance through February 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,824.77 Firm Fixed Price Delivery Order contract is for the supply of ANNOVERA vaginal rings. The contract has an ultimate completion date of January 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVVH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,455.86 Firm Fixed Price Delivery Order contract is for the supply of ANNOVERA vaginal rings, with a period of performance through June 21, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This includes specialty, brand name, generic, and over-the-counter medications, as well as critical care materials. The contract does not have a set-aside designation, indicating it was competed on a full and open basis.

Generated 9/19/24, 9:55 AM